Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$60.95

-0.46 (-0.75%)

, SMMT

Summit Therapeutics

$8.65

-0.414 (-4.57%)

07:08
10/04/16
10/04
07:08
10/04/16
07:08

Sarepta, Summit enter into exclusive license, collaboration agreement

Sarepta Therapeutics (SRPT) and Summit Therapeutics (SMMT) announced that they have entered into an exclusive license and collaboration agreement granting Sarepta rights in Europe, as well as in Turkey and the Commonwealth of Independent States, to Summit's utrophin modulator pipeline, including its lead clinical candidate, ezutromid, for the treatment of Duchenne muscular dystrophy, or DMD. As part of the agreement, Sarepta also obtains an option to license Latin American rights to Summit's utrophin modulator pipeline. Summit retains commercialization rights in all other countries. Utrophin modulation is a potential disease-modifying treatment for all patients with the fatal muscle wasting disease DMD, regardless of their underlying dystrophin gene mutation. Ezutromid is currently in a Phase 2 proof of concept trial called PhaseOut DMD. Under the terms of the agreement, Summit will receive an upfront fee of $40M. In addition, Summit will be eligible for future ezutromid related development, regulatory and sales milestone payments totalling up to $522M, including a $22M milestone upon the first dosing of the last patient in Summit's PhaseOut DMD trial, and escalating royalties ranging from a low to high teens percentage of net sales in the licensed territory.

SRPT

Sarepta

$60.95

-0.46 (-0.75%)

SMMT

Summit Therapeutics

$8.65

-0.414 (-4.57%)

  • 06

    Nov

SRPT Sarepta
$60.95

-0.46 (-0.75%)

09/21/16
LEER
09/21/16
NO CHANGE
LEER
Market Perform
Previous PTAB ruling remains overhang on Sarepta eteplirsen, says Leerink
Leerink analyst Joseph Schwartz notes that Sarepta (SRPT) has announced favorable Patent Trial and Appeal Board of the U.S. Patent and Trademark Office decisions in favor of its exon 51 and 53 composition of matter patent interference cases against BioMarin (BMRN). However, he points out that these rulings are subject to appeal and a previous ruling from the U.S. Patent Trial and Appeal Board, or PTAB, in favor of BioMarin's method of use patent remains an overhang on the commercialization of Sarepta's eteplirsen. The analyst reiterates a Market Perform rating on Sarepta's shares.
09/23/16
PIPR
09/23/16
NO CHANGE
Target $64
PIPR
Overweight
Sarepta stock issuance strengthens balance sheet, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says Sarepta Therapeutics has a strengthened balance sheet after issuing 5.02M shares at a price of $59.75. Further, for its Exondys51 approval, Sarepta gained a Rare Priority Review Voucher that could be sold to further pad the company's cash position, Tenthoff tells investors in an intraday research note. He reiterates an Overweight rating on the shares with a $64 price target. The stock is down 5% to $57.74 in late afternoon trading.
09/28/16
09/28/16
NO CHANGE

Experts 'fairly upbeat' on Sarepta drug, says RBC Capital
After speaking with three neurologists who treat DMD, RBC Capital analyst Simos Simeonidis says that the doctors were "fairly bullish" on Sarepta's DMD treatment, EXONDYS 51. The doctors expect to use the drug "in essentially all eligible patients," according to the analyst. Simeonidis raised the price target on Sarepta to $108 from $83 and keeps an Outperform rating on the stock.
09/28/16
JMPS
09/28/16
NO CHANGE
JMPS
Street underestimating price of Sarepta drug, says JMP Securities
JMP Securities analyst Liisa Bayko expects the price of Sarepta's Exondys 51 drug will be above the company's projected annual net price of $300,000. She thinks that the price will come in "closer to $538,000 per year on a gross basis, $457,000 net of discounts and compliance." The analyst raised her price target on the shares to $90 from $60 and keeps an Outperform rating on the stock.
SMMT Summit Therapeutics
$8.65

-0.414 (-4.57%)

02/01/16
ADAM
02/01/16
INITIATION
Target $14
ADAM
Buy
Summit Therapeutics initiated with a Buy at Canaccord
Target $14.
02/01/16
02/01/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acadia (ACHC) initiated with an Overweight at KeyBanc... Altisource Residential (RESI) initiated with a Neutral at Nomura... Colony Starwood Homes (SFR) initiated with a Buy at Nomura... EyeGate (EYEG) initiated with a Buy at Rodman & Renshaw... Fortinet (FTNT) initiated with an Outperform at Northland... Halozyme (HALO) initiated with a Buy at Canaccord... Lendingtree (TREE) initiated with an Outperform at Northland... Lindblad Expeditions (LIND) initiated with an Outperform at Credit Suisse... Summit Therapeutics (SMMT) initiated with a Buy at Canaccord... VolitionRx (VNRX) initiated with a Buy at Rodman & Renshaw.
06/21/16
JANY
06/21/16
INITIATION
Target $15
JANY
Buy
Summit Therapeutics initiated with a Buy at Janney Capital
Janney Capital analyst Debjit Chattopadhyay started coverage of Summit Therapeutics with a Buy rating and $15 fair value estimate as he believes the company's pre-clinical data has been compelling and that two upcoming data reads should clarify its outlook and provide a catalyst for the stock.
09/16/16
HCWC
09/16/16
INITIATION
Target $26
HCWC
Buy
Summit Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther initiated Summit Therapeutics with a Buy and a $26 price target saying Ezutromid in DMD can potentially generate $1.2B in global sales in FY26.

TODAY'S FREE FLY STORIES

10:55
01/18/18
01/18
10:55
01/18/18
10:55
General news
Euro$ interest rate futures are again lower »

Euro$ interest rate…

NFLX

Netflix

$217.50

-4.03 (-1.82%)

, AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

10:55
01/18/18
01/18
10:55
01/18/18
10:55
Conference/Events
Wedbush digital media analyst hosts a luncheon meeting »

Digital Media Analyst…

NFLX

Netflix

$217.50

-4.03 (-1.82%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

FB

Facebook

$177.60

-0.79 (-0.44%)

TWX

Time Warner

$92.15

-0.02 (-0.02%)

DIS

Disney

$111.37

-0.6 (-0.54%)

FOXA

21st Century Fox

$37.11

0.82 (2.26%)

ROKU

Roku

$41.54

2.35 (6.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

AAL

American Airlines

$58.16

0.18 (0.31%)

10:53
01/18/18
01/18
10:53
01/18/18
10:53
Hot Stocks
American Airlines expands network in 2018, introduces new shuttle »

American recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

LGND

Ligand

$149.33

2.94 (2.01%)

10:49
01/18/18
01/18
10:49
01/18/18
10:49
Periodicals
Breaking Periodicals news story on Ligand »

Ligand moves higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCTT

Ultra Clean

$24.98

1.32 (5.58%)

10:48
01/18/18
01/18
10:48
01/18/18
10:48
Upgrade
Ultra Clean rating change  »

Follow-up: Ultra Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

T

AT&T

$37.05

0.2 (0.54%)

, ARW

Arrow Electronics

$84.26

0.43 (0.51%)

10:46
01/18/18
01/18
10:46
01/18/18
10:46
Hot Stocks
AT&T, Arrow Electronics announce IoT collaboration »

Arrow Electronics (ARW)…

T

AT&T

$37.05

0.2 (0.54%)

ARW

Arrow Electronics

$84.26

0.43 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

QD

Qudian

$12.29

0.1 (0.82%)

10:45
01/18/18
01/18
10:45
01/18/18
10:45
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

Week of 1/12 EIA…

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

CAT

Caterpillar

$168.90

0.4 (0.24%)

, ROSE

Rosehill Resources

$7.96

0.01 (0.13%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CAT

Caterpillar

$168.90

0.4 (0.24%)

ROSE

Rosehill Resources

$7.96

0.01 (0.13%)

ARNA

Arena Pharmaceuticals

$34.36

0.48 (1.42%)

EA

Electronic Arts

$113.14

1.22 (1.09%)

ATVI

Activision Blizzard

$70.36

1.65 (2.40%)

BBU

Brookfield Business Partners

$36.62

-0.18 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 08

    Feb

  • 12

    Feb

  • 21

    Feb

  • 22

    Feb

SYMC

Symantec

$27.52

-0.35 (-1.26%)

, JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

SYMC

Symantec

$27.52

-0.35 (-1.26%)

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

FSLR

First Solar

$72.00

0.78 (1.10%)

CVX

Chevron

$131.82

-0.54 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 26

    Feb

WMT

Walmart

$103.89

1.19 (1.16%)

, HTZ

Hertz

$22.39

1.33 (6.32%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

WMT

Walmart

$103.89

1.19 (1.16%)

HTZ

Hertz

$22.39

1.33 (6.32%)

ALRM

Alarm.com

$38.27

1.26 (3.40%)

PPL

PPL Corp.

$31.80

0.23 (0.73%)

FLR

Fluor

$59.27

1.14 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 16

    May

EXAS

Exact Sciences

$47.68

-5.27 (-9.95%)

10:38
01/18/18
01/18
10:38
01/18/18
10:38
Conference/Events
Exact Sciences management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 26

    Feb

UCTT

Ultra Clean

$24.98

1.32 (5.58%)

10:36
01/18/18
01/18
10:36
01/18/18
10:36
Upgrade
Ultra Clean rating change  »

Ultra Clean upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

BHP

BHP Billiton

$49.15

-0.29 (-0.59%)

10:35
01/18/18
01/18
10:35
01/18/18
10:35
Hot Stocks
BHP Billiton considers options for U.S. shale unit »

In an operational review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$21.19

-1.095 (-4.91%)

10:35
01/18/18
01/18
10:35
01/18/18
10:35
Options
Mallinckrodt put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 08

    Mar

TOL

Toll Brothers

$52.28

0.21 (0.40%)

10:34
01/18/18
01/18
10:34
01/18/18
10:34
Conference/Events
Toll Brothers management to meet with MKM Partners »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

EXEL

Exelixis

$27.49

-2.16 (-7.29%)

, IPSEY

Ipsen

$34.14

2.95 (9.46%)

10:31
01/18/18
01/18
10:31
01/18/18
10:31
Conference/Events
Exelixis and Ipsen co-host a financial community briefing »

Exelixis and Ipsen…

EXEL

Exelixis

$27.49

-2.16 (-7.29%)

IPSEY

Ipsen

$34.14

2.95 (9.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

10:30
01/18/18
01/18
10:30
01/18/18
10:30
General news
EIA natural gas storage change for week ending January 12 »

Gas inventories 183 Bcf…

TIVO

TiVo

$14.50

0.1 (0.69%)

, GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

10:26
01/18/18
01/18
10:26
01/18/18
10:26
Hot Stocks
TiVo rises amid expanded patent license agreement with Google »

Shares of TiVo (TIVO) are…

TIVO

TiVo

$14.50

0.1 (0.69%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

T

AT&T

$37.33

0.48 (1.30%)

SNE

Sony

$49.09

-0.73 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

SNAP

Snap

$13.84

0.315 (2.33%)

, FB

Facebook

$177.60

-0.79 (-0.44%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
SunTrust Internet & digital media analyst holds analyst/industry conference call »

Internet & Digital…

SNAP

Snap

$13.84

0.315 (2.33%)

FB

Facebook

$177.60

-0.79 (-0.44%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

TWTR

Twitter

$23.90

-0.66 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

DIS

Disney

$111.57

-0.4 (-0.36%)

, VIA

Viacom

$37.85

0.95 (2.57%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media Analyst Routh,…

DIS

Disney

$111.57

-0.4 (-0.36%)

VIA

Viacom

$37.85

0.95 (2.57%)

TWX

Time Warner

$92.36

0.1916 (0.21%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

SPB

Spectrum Brands

$123.47

-1.69 (-1.35%)

DISH

Dish

$45.45

-2.54 (-5.29%)

NFLX

Netflix

$217.50

-4.03 (-1.82%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 24

    Jan

  • 30

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

  • 18

    Mar

MDXG

MiMedx

$14.09

0.15 (1.08%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
MiMedx to hold a conference call »

Chairman & CEO Petit,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
Morgan Stanley healthcare analysts hold an analyst/industry conference call »

Healthcare Analyst…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.